Manning Paul B 13D/13G Filings for Verrica Pharmaceuticals Inc. (VRCA)

Manning Paul B 13D and 13G filings for Verrica Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-28
5:10 pm
Purchase
2025-11-2513DVERRICA PHARMACEUTICALS INC CO
VRCA
Manning Paul B8,056,031
49.900%
2,805,626increase
(+53.44%)
Filing